ATE439051T1 - Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit - Google Patents

Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit

Info

Publication number
ATE439051T1
ATE439051T1 AT01926782T AT01926782T ATE439051T1 AT E439051 T1 ATE439051 T1 AT E439051T1 AT 01926782 T AT01926782 T AT 01926782T AT 01926782 T AT01926782 T AT 01926782T AT E439051 T1 ATE439051 T1 AT E439051T1
Authority
AT
Austria
Prior art keywords
methods
compositions
vascular health
improving vascular
polyphenols
Prior art date
Application number
AT01926782T
Other languages
English (en)
Inventor
Harold Schmitz
Kati Chevaux
Amy Dombroski
Ralph Jerome
Original Assignee
Mars Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22728187&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE439051(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mars Inc filed Critical Mars Inc
Application granted granted Critical
Publication of ATE439051T1 publication Critical patent/ATE439051T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/48—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/56—Cocoa products, e.g. chocolate; Substitutes therefor making liquid products, e.g. for making chocolate milk drinks and the products for their preparation, pastes for spreading, milk crumb
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/04—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing vitamins, antibiotics, other medicaments
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
AT01926782T 2000-04-14 2001-04-10 Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit ATE439051T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19713500P 2000-04-14 2000-04-14
PCT/US2001/011542 WO2001078529A2 (en) 2000-04-14 2001-04-10 Compositions and methods for improving vascular health

Publications (1)

Publication Number Publication Date
ATE439051T1 true ATE439051T1 (de) 2009-08-15

Family

ID=22728187

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926782T ATE439051T1 (de) 2000-04-14 2001-04-10 Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit

Country Status (17)

Country Link
US (2) US6610320B2 (de)
EP (1) EP1274319B1 (de)
JP (1) JP4970690B2 (de)
KR (1) KR20030005280A (de)
CN (1) CN1436047A (de)
AT (1) ATE439051T1 (de)
AU (1) AU2001253294A1 (de)
BR (1) BR0110084A (de)
CA (1) CA2405731C (de)
DE (1) DE60139550D1 (de)
ES (1) ES2331724T3 (de)
IL (1) IL152175A (de)
MX (1) MXPA02009956A (de)
PL (1) PL357822A1 (de)
RU (1) RU2303373C2 (de)
WO (1) WO2001078529A2 (de)
ZA (1) ZA200208130B (de)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
DE60139550D1 (de) 2000-04-14 2009-09-24 Mars Inc Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
AU2001282373A1 (en) * 2000-05-26 2001-12-03 Horphag Research Limited Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
FR2812873B1 (fr) * 2000-08-11 2003-08-01 Barry Callebaut France Procede de production de polyphenols a partir de feves de cacao
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
FI20010780A0 (fi) 2001-04-12 2001-04-12 Raisio Benecol Oy Parannetut koostumukset
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie
AU2002347165B2 (en) * 2001-12-11 2008-05-29 Ceapro Inc. Cereal beta glucan compositions, methods of preparation and uses thereof
US7514107B2 (en) * 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
US20040166179A1 (en) * 2002-05-27 2004-08-26 Piergiorgio Anzaghi Dietary supplements from wine vinasses and relevant production process
KR20030097398A (ko) * 2002-06-21 2003-12-31 이노천 양념육용 폴리페놀을 함유한 소스
JP4527938B2 (ja) * 2002-07-23 2010-08-18 オルビス株式会社 抗酸化用の経口投与組成物
KR100567389B1 (ko) * 2002-11-08 2006-04-04 (주)바이오뉴트리젠 폴리페놀계 물질 또는 바이오플라보노이드계 물질을 포함하는 식물의 분말 또는 추출물을 유효성분으로 포함하는 항비만용 탄수화물 식품
US20040258674A1 (en) * 2003-04-10 2004-12-23 Thunder Jalili Quercetin supplementation to treat hypertenstion
AU2004262853B2 (en) 2003-07-17 2008-06-05 Upfield Europe B.V. Process for the preparation of an edible dispersion comprising oil and structuring agent
US8463996B2 (en) * 2003-08-19 2013-06-11 Oracle America, Inc. Multi-core multi-thread processor crossbar architecture
WO2005027662A1 (en) * 2003-09-12 2005-03-31 Ray And Terry's Health Products, Inc. Meal replacement beverage
US7329429B2 (en) * 2003-09-25 2008-02-12 Chimel Mark J Bars and confectioneries containing cocoa solids having a high cocoa polyphenol content and sterol/stanol esters and processes for their preparation
US7160771B2 (en) * 2003-11-28 2007-01-09 International Business Machines Corporation Forming gate oxides having multiple thicknesses
EP1713467B1 (de) * 2004-01-28 2012-08-01 Mars, Incorporated Zusammensetzungen und verfahren zur verwendung von procyanidinen vom a-typ
KR100656241B1 (ko) 2004-09-10 2006-12-11 롯데제과주식회사 고지혈증 및 혈소판 응집에 대해 억제작용을 갖는대두발효 추출물과 이를 이용한 조성물
JP2006087352A (ja) * 2004-09-24 2006-04-06 Meiji Seika Kaisha Ltd Ｌｄｌ酸化抑制組成物
WO2006063219A2 (en) * 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
WO2006061915A1 (ja) * 2004-12-09 2006-06-15 Toyo Shinyaku Co., Ltd. 皮膚改善組成物
US20060134235A1 (en) * 2004-12-22 2006-06-22 Toyo Shinyaku Co., Ltd. External preparation for improving blood flow
ES2436181T3 (es) 2004-12-29 2013-12-27 Hill's Pet Nutrition Inc. Métodos para inhibir un declive en el aprendizaje y/o la memoria en animales
AU2006215829B2 (en) 2005-02-17 2009-07-09 Upfield Europe B.V. Process for the preparation of a spreadable dispersion
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
BRPI0613321A2 (pt) * 2005-06-03 2011-01-04 Horizon Science Pty Ltd sistema de distribuição de droga para um pó bioativo, produto do chocolate que tem uma distribuição uniforme de um pó bioativo que compreende o sistema de distribuição de droga, método para a distribuição de pós bioativos , uso de um lipìdio, produto de cacau que tem uma distribuição uniforme de um pó bioativo, método para a manufatura de um produto de chocolate que compreende um pó bioativo, método para melhorar a biodisponibilidade de um pó bioativo lipofìlico, método para minimizar o nìvel de degradação de um pó bioativo,método para a incorporação de substáncias bioativas em produtos de cacau, produto de chocolate ao vinho, método pra intensificar a absorção de um polifenol no sangue de um ser humano e método para promover a saúde vascular de um ser humano
CA2611860A1 (en) * 2005-06-28 2007-01-04 Mars, Incorporated Compositions and methods of use of derivatized flavanols
RU2435578C2 (ru) * 2005-06-29 2011-12-10 Марс, Инкорпорейтед Возбуждение вазодилатации периферических кровеносных сосудов
CA2615060C (en) 2005-07-14 2016-06-21 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
KR100712651B1 (ko) * 2005-07-29 2007-05-02 담양군 초콜릿 조성물 및 그 제조방법
US20070026126A1 (en) * 2005-08-01 2007-02-01 Bryan Hitchcock Sterol fortified beverages
US20070042102A1 (en) * 2005-08-22 2007-02-22 Furcich Steven J Methods of forming phytosterol-fortified cocoa powder and the product formed therefrom
US20070060651A1 (en) * 2005-08-26 2007-03-15 Nestec S.A. Compositions and methods for improving functional vascular cellular survival integrity and reducing apoptosis in ischemia
AU2011221341B2 (en) * 2005-08-26 2013-11-28 Nestec S.A. Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US7976879B2 (en) * 2005-11-04 2011-07-12 Roizen Michael F Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions
US20070104762A1 (en) * 2005-11-04 2007-05-10 Roizen Michael F Appetizer supplement to suppress age-related decline in capacity and appetite
ES2281270B1 (es) 2005-11-30 2008-07-01 La Morella Nuts, S.A. Alimento funcional con efectos positivos en la prevencion de enfermedades cardiovasculares.
JP4807563B2 (ja) * 2005-12-06 2011-11-02 株式会社 伊藤園 容器詰め飲料及びその製造方法
CA2634127C (en) * 2005-12-23 2016-06-07 Mars, Incorporated Skin protection and improvement
US20070219146A1 (en) * 2006-02-06 2007-09-20 Sunil Bhaskaran Synergistic Pharmaceutical And/Or Neutraceutical Flavanoid Composition For Management Of Diabetes Mellitus
JP2009527487A (ja) * 2006-02-16 2009-07-30 ザ ハーシー カンパニー ココア製品及び心血管状態を無糖ココアで処置する方法
US20070218113A1 (en) * 2006-02-28 2007-09-20 Miller Debra L Health bars and compositions for improving cardiovascular risk factors
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1991212A1 (de) * 2006-03-08 2008-11-19 Braincells, Inc. Neurogenesemodulation durch nootropika
WO2007116819A1 (ja) * 2006-03-31 2007-10-18 Fuji Oil Company, Limited 蛋白含有油性食品
US8110231B2 (en) * 2006-04-10 2012-02-07 Kraft Foods Global Brands Llc Methods for making improved texture cereal bars
DE602006010811D1 (de) * 2006-04-10 2010-01-14 Barilla Flli G & R Nahrungsmittelriegel enthaltend funktionelle Zutaten (Vitamin C und E, Catechine) zur Verhinderung von Degenerationphänomenen, die durch Oxidationsmitteln verursacht werden
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2382975A3 (de) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenese mittels Angiotensin-Modulation
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007137449A1 (fr) * 2006-05-29 2007-12-06 Fenchem Enterprises Ltd. Compositions de traitement et de prévention de l'hyperlipidémie
US8821947B2 (en) * 2006-06-01 2014-09-02 Howard W. Selby, III Cholesterol-reducing diet
US20070299017A1 (en) * 2006-06-23 2007-12-27 Kanter Mitchell M Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2663347A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Ppar mediated modulation of neurogenesis
US9114114B2 (en) * 2007-06-21 2015-08-25 Mars, Inc. Edible products having a high cocoa polyphenol content and improved flavor and the milled cocoa extracts used therein
EP2033526A1 (de) * 2007-09-07 2009-03-11 Probelte Pharma, S.A. Nahrungsmittel mit ellagitanninhaltigen Granatapfelextrakten und ihre Verwendung
CN104224835A (zh) * 2007-10-25 2014-12-24 营养株式会社 用于降低血中的糖、丙二醛修饰ldl、同型半胱氨酸和/或c反应蛋白的组合物
WO2009064806A1 (en) * 2007-11-12 2009-05-22 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
GB0801119D0 (en) 2008-01-22 2008-02-27 Barry Callebaut Ag Composition
EP2090178A1 (de) * 2008-02-13 2009-08-19 Bühler AG Haustier-Nahrungsmittelprodukt und Verfahren zu seiner Herstellung
US20090214654A1 (en) * 2008-02-21 2009-08-27 Isenburg Jason C Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
US20100016833A1 (en) * 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
UA102112C2 (ru) * 2008-08-29 2013-06-10 Тропикана Продактс, Инк. Натурально подслащенный соковый продукт с бета-глюканом
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
US8865245B2 (en) 2008-12-19 2014-10-21 Conopco, Inc. Edible fat powders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5569716B2 (ja) * 2009-06-23 2014-08-13 独立行政法人国立循環器病研究センター レクチン様酸化ｌｄｌ受容体阻害用医薬品
RU2505073C2 (ru) * 2009-07-14 2014-01-27 Хилл'С Пет Ньютришн, Инк. Композиции корма для домашних животных, включающие липоевую кислоту с замедленным высвобождением, и способы их получения и применения
RU2472502C2 (ru) * 2009-08-11 2013-01-20 Индус Биотек Прайвет Лимитед Новая стандартизованная композиция, способ ее получения и применение в регрессии рнк-вирусной инфекции
EP2485687A1 (de) * 2009-10-09 2012-08-15 Vatrix Medical, Inc. Chemische in-vivo-stabilisierung empfindlicher plaque
US8444624B2 (en) * 2009-10-19 2013-05-21 Vatrix Medical, Inc. Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
MX2012014628A (es) 2010-06-22 2013-02-07 Unilever Nv Polvos de grasa comestibles.
ES2372381B1 (es) * 2010-06-29 2012-11-28 La Morella Nuts, S.A. Ingrediente reconstituido de fruto seco y/o algarroba.
CA2820354C (en) 2010-12-17 2019-06-11 Unilever Plc Process of compacting a microporous fat powder and compacted fat powder so obtained
HUE026515T2 (en) 2010-12-17 2016-06-28 Unilever Bcs Europe Bv Edible water-in-oil emulsion
FR2969496B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de pulpe et/ou de peau d'avocat riche en polyphenols et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
JP2012213339A (ja) * 2011-03-31 2012-11-08 Lotte Co Ltd 植物性ステロール配合チョコレートおよびその製造方法
EP2709711B8 (de) 2011-05-18 2017-03-22 Vatrix Medical, Inc. Beschichtete ballons zur blutgefässstabilisierung
WO2012171001A2 (en) * 2011-06-10 2012-12-13 Ambo Innovations, Llc Food products containing beta-glucans and omega-3 fatty acids
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
WO2016060259A1 (ja) * 2014-10-17 2016-04-21 株式会社明治 ポリフェノール含有機能性経口組成物
US11173187B2 (en) * 2018-11-13 2021-11-16 Immortazyme Company Ltd. Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition
US20220378771A1 (en) * 2021-05-25 2022-12-01 Louis Habash Modifying the expression level of a gene encoding an cyclooxygenase enzyme by treating a human subject with a nitroxide

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1099627A (en) 1975-09-11 1981-04-21 David J. Horvath Piezoelectric ignition system for gas burners
WO1983001924A1 (en) 1981-12-03 1983-06-09 Acf Ind Inc Filament wound vessel
US4883788A (en) * 1986-06-06 1989-11-28 Hauser-Kuhrts, Inc. Method and composition for reducing serum cholesterol
US4808574A (en) * 1986-12-03 1989-02-28 Nauchno-Issledovatelsky Institut Sadovodstva Composition inhibiting pathological addiction to alcohol
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
JPS63214183A (ja) * 1987-03-03 1988-09-06 Mitsui Norin Kk アンジオテンシン１変換酵素阻害剤
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
PL166991B1 (pl) 1991-05-03 1995-07-31 Raision Margariini Oy Sposób wytwarzania substancji obnizajacej poziom cholesterolu w surowicy krwi PL PL PL
US5244887A (en) 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
CN1099627A (zh) 1993-08-30 1995-03-08 江苏省肿瘤防治研究所 一种用松针制备抗癌扶正冲剂的方法
US5554645A (en) 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
FI955691A (fi) 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
JPH09291039A (ja) * 1995-12-26 1997-11-11 Suntory Ltd プロシアニジンを有効成分とする抗肥満剤
ES2230573T3 (es) * 1995-12-26 2005-05-01 Suntory Limited Agente anti-obesidad cuyo principio activo es la procianidina.
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
CA2250792C (en) * 1996-04-02 2011-09-13 Mars, Incorporated Cocoa extract compounds and methods for making and using the same
US6297273B1 (en) * 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
US6469053B1 (en) * 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
BR9708545A (pt) 1996-04-09 1999-08-03 Du Pont Produto de proteína de soja método para a fabricação de um produto de proteína de soja produto substituinte do leite formulação para crianças pó ou líquido de bebida nutritivo pasta de queijo produto de presunto bologna produto de iogurte e sobremesa congelada
FI107015B (fi) 1996-08-09 2001-05-31 Raisio Benecol Oy Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike
US6312753B1 (en) * 1996-09-06 2001-11-06 Mars, Incorporated Cocoa components, edible products having enriched polyphenol content, methods of making same and medical uses
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans
FI105887B (fi) 1996-09-27 2000-10-31 Suomen Sokeri Oy Elintarvike- ja terapeuttisiin sovelluksiin käyttökelpoiset, kasvisterolia sisältävät tuotteet, menetelmä niiden valmistamiseksi ja niiden käyttö
FI120290B (fi) * 1996-12-30 2009-09-15 Mirador Res Oy Ltd Menetelmä, jonka avulla voidaan valmistaa sellaisia mausteseos-, ruoan ainesosa- ja elintarvikekoostumuksia, jotka alentavat seerumin kolesterolia
WO1998033494A1 (en) 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
FI108110B (fi) 1997-06-13 2001-11-30 Danisco Finland Oy Elintarvike- ja eläinravitsemusalalla käyttökelpoinen esiseos, menetelmä sen valmistamiseksi ja sen käyttö
AU8257898A (en) * 1997-06-17 1999-01-04 Rutgers, The State University Of New Jersey Hypocholesterolemic compositions from bamboo shoots
DE69826592T2 (de) 1997-08-22 2006-02-23 Unilever N.V. Verfahren zur Herstellung von Stanolestern
DK1298194T3 (da) 1997-08-22 2006-11-27 Unilever Nv Staniolholdige sammensætninger
AU9209898A (en) 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
FI974648A (fi) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US6228993B1 (en) 1998-10-12 2001-05-08 Central Soya Company, Inc. Soy isoflavone concentrate process and product
US6394230B1 (en) 1997-12-16 2002-05-28 Cognis Corporation Sterol esters as food additives
US5985936A (en) 1997-12-18 1999-11-16 Forbes Medi-Tech, Inc. Method of preventing and delaying onset of Alzheimer's disease and composition therefor
FI109327B (fi) 1998-02-27 2002-07-15 Spice Sciences Oy Menetelmä seerumin kokonais- ja LDL-kolestrolipitoisuutta alentavan beta-sitosterolin rasvamaisen seoksen valmistamiseksi
US6132795A (en) 1998-03-15 2000-10-17 Protein Technologies International, Inc. Vegetable protein composition containing an isoflavone depleted vegetable protein material with an isoflavone containing material
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
US6025348A (en) 1998-04-30 2000-02-15 Kao Corporation Oil and fat composition containing phytosterol
WO1999053925A1 (en) 1998-04-17 1999-10-28 Medical Isotopes Inc. Phytosterol formulations to lower cholesterol absorption
SE512958C2 (sv) 1998-04-30 2000-06-12 Triple Crown Ab Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
US6087353A (en) 1998-05-15 2000-07-11 Forbes Medi-Tech Inc. Phytosterol compositions and use thereof in foods, beverages, pharmaceuticals, nutraceuticals and the like
US5932562A (en) 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
JP2002517418A (ja) 1998-06-05 2002-06-18 フォーブス メディ−テック インコーポレーテッド 高められた溶解性および分散性を有するフィトステロールおよび／またはフィトスタノ−ルよりなる組成物
US6013771A (en) 1998-06-09 2000-01-11 Protein Technologies International, Inc. Isoflavone rich protein isolate and process for producing
US6150399A (en) 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
US5892068A (en) 1998-08-25 1999-04-06 Mcneil-Ppc, Inc. Preparation of sterol and stanol-esters
WO2000015201A2 (en) 1998-09-10 2000-03-23 Forbes Medi-Tech Inc. Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other disorders
AU6405899A (en) 1998-10-26 2000-05-15 Galagen, Inc. Soy and immunoglobulin compositions
EP1129628B1 (de) 1998-11-09 2008-06-25 Taiyo Kagaku Co., Ltd. Zusatz zur verbesserung der gefluegelproduktivitaet sowie verfahren zur verbesserung der gefluegelproduktivitaet
EP1133308B1 (de) 1998-11-25 2003-11-12 Nutri Pharma ASA Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
JP2002530346A (ja) 1998-11-25 2002-09-17 ニュートリ・ファーマ・アルメント・アクシェセルスカブ 大豆蛋白質、食物繊維およびフィトエストロゲン化合物を含む組成物、および肺疾患の予防および／または治療におけるその使用
JP2003524610A (ja) 1998-11-25 2003-08-19 ニュートリ・ファーマ・アルメント・アクシェセルスカブ 大豆蛋白質、食物繊維およびフィトエストロゲン化合物を含む組成物、および２型糖尿病、代謝症候群および関連する心臓血管疾患の予防および／または治療におけるその使用
US6242001B1 (en) 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
EP1171119A1 (de) 1999-04-20 2002-01-16 The Board Of Trustees Of Southern Illinois University Methoden zur behandlung klinischer erkrankungen mit isoflavonen
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US5972345A (en) 1999-05-03 1999-10-26 Chizick; Stephen Natural preparation for treatment of male pattern hair loss
US6426112B1 (en) 1999-07-23 2002-07-30 University Of Kentucky Research Foundation Soy products having improved odor and flavor and methods related thereto
NZ505933A (en) 1999-07-26 2002-11-26 Mcneil Ppc Inc Incorporation of cholesterol lowering agents into confectionery dosage forms
US6313273B1 (en) 1999-08-25 2001-11-06 Abbott Laboratories Soy proteins and methods for their production
AU1135701A (en) 1999-10-14 2001-04-23 Schroeder, Fritz H. Compositions with anti-prostate cancer activity
WO2001037781A2 (en) 1999-10-28 2001-05-31 Ingredient Innovations International A stable aqueous dispersion of nutrients
DE60017443T2 (de) * 1999-11-03 2005-06-09 Forbes Medi-Tech Inc., Vancouver Zusammensetzungen mit essbaren ölen oder fetten und darin aufgelösten phytosterolen und/oder phytostanolen
US6207702B1 (en) * 1999-11-17 2001-03-27 Mars, Incorporated Method for reducing postprandial oxidative stress using cocoa procyanidins
FI20000004A0 (fi) 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke...
WO2001051088A1 (en) 2000-01-07 2001-07-19 Anthony Cincotta Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
DE60139550D1 (de) 2000-04-14 2009-09-24 Mars Inc Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
US6797309B2 (en) 2000-08-18 2004-09-28 Solae, Llc Soy protein product and process for its manufacture

Also Published As

Publication number Publication date
CN1436047A (zh) 2003-08-13
CA2405731A1 (en) 2001-10-25
BR0110084A (pt) 2002-12-31
ES2331724T3 (es) 2010-01-14
WO2001078529A2 (en) 2001-10-25
CA2405731C (en) 2012-09-18
JP2003530410A (ja) 2003-10-14
RU2002130509A (ru) 2004-03-27
KR20030005280A (ko) 2003-01-17
WO2001078529A3 (en) 2002-03-21
EP1274319A2 (de) 2003-01-15
RU2303373C2 (ru) 2007-07-27
EP1274319B1 (de) 2009-08-12
PL357822A1 (en) 2004-07-26
IL152175A (en) 2005-08-31
AU2001253294A1 (en) 2001-10-30
MXPA02009956A (es) 2003-02-12
US20040081715A1 (en) 2004-04-29
JP4970690B2 (ja) 2012-07-11
US20020018807A1 (en) 2002-02-14
IL152175A0 (en) 2003-05-29
ZA200208130B (en) 2004-01-22
DE60139550D1 (de) 2009-09-24
US6610320B2 (en) 2003-08-26

Similar Documents

Publication Publication Date Title
ATE439051T1 (de) Zusammensetzungen und methoden zur verbesserung der vaskulären gesundheit
EP2332527A3 (de) Flavanoide und Isoflavanoide für die Prävention und Behandlung von kardiovaskulären Erkrankungen
IL183953A0 (en) Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood
MY127247A (en) New pharmaceutical composition
WO2001068135A3 (en) Compositions and methods for affecting osteogenesis
UA34768A (uk) Склад для обробки пар тертя
MXPA04001523A (es) Dialdehidos de rapamicina.
IS6557A (is) Blandaðar sjúkdómsmeðferðir úr blóðþrýstingslækkandi efnum og efnum sem hamla æðamyndun
ATE371475T1 (de) Methoden zur behandlung der hautpigmentierung
MXPA04001524A (es) 29-enoles de rapamicina.
HUP0203652A2 (hu) GCSF-konjugátumok
MXPA04005517A (es) Composiciones farmaceuticas bajo forma de gel o solucion a base de dihidrotestosterona, su metodo de preparacion y sus usos.
PL373465A1 (en) Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives
EA200870526A1 (ru) Композиция, включающая по меньшей мере один высший алифатический спирт и экстракт griffonia simplicifolia
IL185539A0 (en) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method compositions containing same and use
HU229456B1 (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
WO2005118946A3 (en) Self-steaming benefit composition
WO2001089520A3 (en) Dehydroascorbic acid formulations and uses thereof
ATE319479T1 (de) Verfahren zur erhöhen der bioverfügbarkeit und dem eindringen in gefässe von azithromycin
NO20060420L (no) 2-aminobenzoylderivater
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
DK0885005T3 (da) Anvendelse af dehydroepiandrosteron og aromatasehæmmere til fremstilling af et lægemiddel til behandling af en relativ og absolut androgenmangel hos mænd
MXPA03011128A (es) Composicion de sabor y fragancia.
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties